These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26209753)

  • 1. Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients.
    Wang XQ; Lv B; Wang HF; Zhang X; Yu SY; Huang XS; Zhang JT; Tian CL; Lang SY
    Clin Neurol Neurosurg; 2015 Nov; 138():1-7. PubMed ID: 26209753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients.
    Sultan SJ; Sameem F; Ashraf M
    Int J Dermatol; 2015; 54(5):537-42. PubMed ID: 24738653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J; Maragno L; Santi CG; Criado PR
    Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dress syndrome and fulminant hepatic failure induced by lamotrigine.
    Amante MF; Filippini AV; Cejas N; Lendoire J; Imventarza O; Parisi C
    Ann Hepatol; 2009; 8(1):75-7. PubMed ID: 19221540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of drug-induced hypersensitivity syndrome in 38 patients.
    Um SJ; Lee SK; Kim YH; Kim KH; Son CH; Roh MS; Lee MK
    J Investig Allergol Clin Immunol; 2010; 20(7):556-62. PubMed ID: 21313995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.
    Myers AP; Watson TA; Strock SB
    Pharmacotherapy; 2015 Mar; 35(3):e9-e12. PubMed ID: 25756365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
    J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?
    Martínez-Cabriales SA; Rodríguez-Bolaños F; Shear NH
    Am J Clin Dermatol; 2019 Apr; 20(2):217-236. PubMed ID: 30652265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lamotrigine induced hypersensitivity syndrome in children: a case report].
    Cui NX; Zhu XP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):356-358. PubMed ID: 30996382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRUG-INDUCED HYPERSENSITIVITY SYNDROME CAUSED BY LAMOTRIGINE, A CASE REPORT.
    Vrhovski D; Ikić Matijašević M; Nesek Adam V
    Acta Clin Croat; 2022 Jun; 61(Suppl 1):88-92. PubMed ID: 36304802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
    Pereira de Silva N; Piquioni P; Kochen S; Saidon P
    Eur J Clin Pharmacol; 2011 May; 67(5):463-70. PubMed ID: 21359537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes].
    Veyrac G; Marcade G; Chiffoleau A; Bourin M; Jolliet P
    Therapie; 2002; 57(3):289-96. PubMed ID: 12422544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
    Roquin G; Peres M; Lerolle N; Dib N; Mercat A; Croue A; Augusto JF
    Ann Pharmacother; 2010 Dec; 44(12):1998-2000. PubMed ID: 21098750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?
    Sarajärvi P; Kubin M; Tasanen K; Huilaja L
    Duodecim; 2017; 133(1):43-51. PubMed ID: 29199808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine induced DRESS syndrome.
    Naveen KN; Ravindra MS; Pai VV; Rai V; Athanikar SB; Girish M
    Indian J Pharmacol; 2012; 44(6):798-800. PubMed ID: 23248415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.
    Mehrholz D; Urban AE; Herstowska M; Nowicki R; Cubała W; Barańska-Rybak W
    Psychiatr Pol; 2017 Dec; 51(6):1079-1093. PubMed ID: 29432504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of lamotrigine-induced drug adverse reaction under tocilizumab treatment with clinical and virological features of drug-induced hypersensitivity syndrome.
    Iriki H; Ouchi T; Ito H; Sawada M; Mukai M; Nomura H; Baba Y; Adachi T; Funakoshi T; Amagai M; Takahashi H
    J Dermatol; 2018 Jun; 45(6):738-741. PubMed ID: 29569382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.